Data protection Impressum

Newsroom

Vaud cleantech Composite Recycling has reached a major milestone with the installation of its first industrial-scale recycling plant in Nantes, France. The move sets the stage for the Ecublens-based company to expand its operations and meet the growing global demand for sustainable composite waste solutions.

Composite Recycling delivers its first industrial-scale recycling unit

15 January 2025

The Métiers du Temps | Time Arts (MTTA) project, a cutting-edge watchmaking initiative in Neuchâtel, has received national recognition from the Swiss Confederation. The project, led by Microcity, has been awarded CHF 1.6 million over four years (2025-2028) by the Federal Department of Economic Affairs, Education and Research (EAER).

Neuchâtel’s MTTA recognized as a nationally significant research infrastructure

13 January 2025

nsave has secured USD 18 million in Series A funding to expand its services, offering customers from high-inflation countries access to U.S. equities, ETFs, and investment funds.

Geneva-based fintech nsave raises USD 18 million

13 January 2025

Bernese tech start-up Soobr, a pioneer in AI-driven cleaning optimization, has entered its sixth European market with an expansion into Denmark. The company doubled its revenue in 2024 and grew its client base to 70, including several prominent healthcare institutions.

AI-driven cleaning specialist Soobr expands into Denmark and doubles revenue in 2024

13 January 2025

Fribourg-based digital health start-up Neuria, a spin-off from the University of Fribourg, is set to launch its patented brain recalibration platform in Switzerland and the US.

Fribourg’s Neuria prepares to launch its brain recalibration platform

13 January 2025

Actival, a medtech spin-off from CSEM, has received CHF 150,000 from Venture Kick to launch its Active Aligners, a groundbreaking solution addressing the hygiene challenges of traditional clear aligners.

Neuchâtel’s Actival receives Venture Kick support to launch its innovative dental aligners

8 January 2025

Vanarix, a Biopôle-based start-up specializing in cartilage regeneration, has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for its bioengineered cartilage mini-implants, Cartibeads.

Vanarix secures FDA Orphan Drug designation for its Cartibeads

7 January 2025

Vandria, a Lausanne-based biotech pioneer in mitochondrial therapeutics, has dosed the first participants in a Phase 1 clinical trial for its lead compound, VNA-318, marking a critical step toward addressing neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

Vandria begins clinical trials for Alzheimer’s drug VNA-318

7 January 2025

Royal Cosun, a leading Dutch agricultural cooperative, has invested CHF 3 million in Geneva-based fermentation scale-up Planetary SA. This partnership aims to advance the development and commercialization of sustainable, plant-based food ingredients, leveraging Planetary’s innovative BioBlocks fermentation technology.

Royal Cosun invests CHF 3 million in Planetary to advance sustainable fermentation

6 January 2025

ONWARD Medical has achieved a significant milestone with FDA de novo classification and market authorization for its non-invasive ARC-EX System, the first technology approved to enhance hand strength and sensation after chronic spinal cord injury.

ONWARD Medical receives FDA authorization for its spinal cord stimulation system

6 January 2025

1 … 7 8 9 10 11 12 13 14 15 … 138